Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
Main Authors: | , , , , , |
---|---|
Format: | Conference item |
Published: |
2005
|
_version_ | 1826257582414626816 |
---|---|
author | Lawson, C Griffiths, B Ponchel, F Hale, G Waldmann, H Isaacs, J |
author_facet | Lawson, C Griffiths, B Ponchel, F Hale, G Waldmann, H Isaacs, J |
author_sort | Lawson, C |
collection | OXFORD |
description | |
first_indexed | 2024-03-06T18:20:29Z |
format | Conference item |
id | oxford-uuid:061a7577-998b-4687-8e0a-2ce7bc269745 |
institution | University of Oxford |
last_indexed | 2024-03-06T18:20:29Z |
publishDate | 2005 |
record_format | dspace |
spelling | oxford-uuid:061a7577-998b-4687-8e0a-2ce7bc2697452022-03-26T09:00:54ZAglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety studyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:061a7577-998b-4687-8e0a-2ce7bc269745Symplectic Elements at Oxford2005Lawson, CGriffiths, BPonchel, FHale, GWaldmann, HIsaacs, J |
spellingShingle | Lawson, C Griffiths, B Ponchel, F Hale, G Waldmann, H Isaacs, J Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title | Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title_full | Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title_fullStr | Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title_full_unstemmed | Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title_short | Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study |
title_sort | aglycosyl anti cd3 monoclonal antibody therapy in rheumatoid arthritis results of a pilot safety study |
work_keys_str_mv | AT lawsonc aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy AT griffithsb aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy AT ponchelf aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy AT haleg aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy AT waldmannh aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy AT isaacsj aglycosylanticd3monoclonalantibodytherapyinrheumatoidarthritisresultsofapilotsafetystudy |